Lifitegrast

FDA Drug Profile — Xiidra, Lifitegrast

Lifitegrast is listed in the FDA National Drug Code directory with 15 NDC codes, marketed under brand names including Xiidra, Lifitegrast. Available dosage forms: powder, solution/ drops, for solution.

Drug Details

Generic Name
Lifitegrast
Brand Names
Xiidra, Lifitegrast
Application Number
NDA208073
Sponsor
Dr. Reddys Laboratories Limited
NDC Codes
15
Dosage Forms
POWDER, SOLUTION/ DROPS, FOR SOLUTION
Routes
OPHTHALMIC
Active Ingredients
LIFITEGRAST

Indications and Usage

1 INDICATIONS AND USAGE Lifitegrast ophthalmic solution 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED). Lifitegrast ophthalmic solution 5% is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease (DED).